WFH news
-
CSL Behring today renews commitment to WFH
CSL Behring today announced that the company has renewed its commitment as a Visionary Corporate Partner with the WFH for another three years. This is...
-
WFH Medical Advisory Board (MAB) supports MASAC’s recommendation on the use and management of emicizumab-kxwh (Hemlibra®) for hemophilia A with and without inhibitors
On December 6, 2018, MASAC—the NHF’s Medical and Scientific Advisory Council—published recommendation #255 entitled, “Recommendation on the Use and Management of Emicizumab-kxwh (Hemlibra®) for Hemophilia...
-
WBDR hits 1,000 patient milestone
The World Federation of Hemophilia (WFH) is happy to announce that on November 28th, 2018 the World Bleeding Disorders Registry (WBDR) reached an important milestone:...
-
Now available: report on the Annual Global Survey 2017
The Report on the World Federation of Hemophilia (WFH) Annual Global Survey (AGS) 2017 is now available in print and online at www.wfh.org/globalsurvey. The report includes...
-
Eric Stolte assumes Presidency of WFH USA
On behalf of the Board of Directors, World Federation of Hemophilia (WFH) President Alain Weill is pleased to announce that long-time volunteer and former WFH...
